![Chulani Karunatilake](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : - $ au 30/06/2026
Chulani Karunatilake is currently Chief Technology Officer at Werewolf Therapeutics, Inc. since 2021.
Formerly, Dr. Karunatilake was Vice President at Nektar Therapeutics and Senior Vice President-Technical Operations at Maverick Therapeutics, Inc. Education includes a doctorate from the University of Illinois and an undergraduate degree from the University of Colombo.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/01/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 15/06/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colombo
 University of Colombo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
